Orbital Tumor Board: lifesaver or timewaster?
Session type: Poster / e-Poster / Silent Theatre session
Orbital tumour board is a multidisciplinary approach towards ophthalmic cancer management, where relevant experts collaborate to manage patients holistically. Studies corroborate the notion that tumor boards positively affect patient outcomes. However, there is a scarcity of literature on the influence of orbital tumor boards globally and about tumor boards in general in Pakistan. There is no existing literature about orbital tumor boards in Pakistan. This study aims to assess the impact of tumor boards in managing ophthalmic cancers.
A retrospective review of data was carried out on cases that were presented in the orbital tumor board of Aga Khan University Hospital, the first orbital tumour board in Pakistan, from its commencement in August 2017 to March 2019.
Out of a total of 98 patients in the study, 60.2% (n=59) were males and 39.8%(n=39) were females. The age of the patients ranged from 3 months to 78 years with the median being 31.3 years. For analysis we divided the patients in three groups according to the nature of the diagnosis. Group 1 included those who had malignant tumours 43.88% (n=43 patients), group 2 were those with benign tumours 30.61% (n=30 patients) and group 3 was the non tumour group who were eventually diagnosed with other conditions 25.51% (n=25 patients). Overall, 37.8% (n=37) of all cases had a change in management plan, which was recorded, which included 17 patients in the malignant group, 13 in the benign group and 7 in the non tumour group.
The rationale for introducing multidisciplinary teams is that as the management of disease becomes more complex, it is important to involve all key professional groups in making clinical decisions for individual patients. There is limited literature available on ophthalmic tumour boards’ effectiveness, however in our experience, orbital tumor board influenced change in management for 37.8% cases delineating that the management and therefore outcome of ophthalmic cancers is influenced significantly by tumor board discussions.